Outsourced Pharma Capacity Update Videos - Cell & Gene
-
Kincell Bio Capacity Update April 2025: Cell & Gene Therapy
4/24/2025
Explore how expert CMC strategies and clinical manufacturing experience can lay the groundwork for the successful commercialization of advanced cell therapies.
-
Capacity Update April 2025: Cell & Gene Therapy
4/24/2025
Witness how NYBCe and CCS are transforming cell and gene therapy development with end-to-end CDMO solutions, advanced logistics, and a growing innovation hub in Louisville.
-
Miltenyi Biotec B.V. & Co. KG Capacity Update April 2025: Cell & Gene Therapy
4/24/2025
In this presentation, Shaan Gareeb highlights the capabilities of our Cell Therapy Center of Excellence in San Jose, California, one of five global Miltenyi Bioindustry sites.
-
Optimization-By-Design: A Critical Factor In Viral Vector Scale Up, Scale Down
4/24/2025
Focusing on critical parameters such as cell culture conditions, viral vector yield, and downstream purification strategies, can drive the success of scale-up and scale-down models for AAV production.
-
SK pharmteco Capacity Update April 2025: Cell & Gene Therapy
4/24/2025
Our integrated expertise — from plasmid science to viral vector and cell therapy manufacturing — can accelerate and de-risk the development of your advanced therapies.
-
Advancing Cell & Gene Therapies To Patients
4/24/2025
Discover how we apply our expertise and know-how to efficiently advance your viral vector-based therapeutic through any phase, while enhancing quality and de-risking production.